International prognostic index (IPI) effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma.

被引：0
|
作者：
Cortelazzo, S
Rossi, A
Roggero, E
Oldani, E
Zucca, E
Tondini, C
Ambrosetti, A
Pinotti, G
Bertini, M
Busetto, M
Gianni, L
Cavalli, F
Barbui, T
机构：
[1] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[2] Ist Nazl Tumori, I-20133 Milan, Italy
[3] Univ Verona, Cattedra Ematol, I-37100 Verona, Italy
[4] Osped Circolo, Fdn Macchi, Varese, Italy
[5] Azienda Osped S Giovanni Battista, Turin, Italy
[6] Osped Umberto 1, Mestre, Italy
[7] Osped Infermi, Rimini, Italy
[8] Osped San Giovanni, Serv Oncol Cantonale, Bellinzona, Switzerland
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2577
引用
收藏
页码：625A / 625A
页数：1
相关论文
共 50 条
  • [31] International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma
    Mu, Shidai
    Shi, Deyao
    Ai, Lisha
    Fan, Fengjuan
    Peng, Fei
    Sun, Chunyan
    Hu, Yu
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [32] Clinical Significance of Prognostic Nutritional Index for Patients with Diffuse Large B-cell Lymphoma
    Yu, Wenjuan
    Guo, Qi
    Wang, Zhaoming
    Mao, Liping
    Wei, Juying
    Jin, Jie
    Wang, Jinghan
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2019, 71 (04): : 569 - 574
  • [33] Clinical Significance of CMYC Rearrangement in Diffuse Large B-Cell Lymphoma.
    Caponetti, G. C.
    Dave, B.
    Smith, L.
    Meyer, P.
    Bast, M.
    Bierman, P.
    Bociek, G.
    Vose, J.
    Armitage, J. O.
    Aoun, P.
    Fu, K.
    Greiner, T.
    Chan, W. C.
    Weisenburger, D.
    MODERN PATHOLOGY, 2011, 24 : 288A - 288A
  • [34] Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP
    Zhou, Qinjun
    Wei, Yongqiang
    Huang, Fen
    Wei, Xiaolei
    Wei, Qi
    Hao, Xiaoxiao
    Zhang, Yuankun
    Feng, Ru
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (04) : 485 - 490
  • [35] International prognostic index (IPI) predicts outcome after histological transformation of low grade non-Hodgkin lymphoma.
    Micallef, INM
    Remstein, ED
    Ansell, SM
    Lewis, JT
    Ristow, K
    Habermann, TM
    BLOOD, 2001, 98 (11) : 336A - 336A
  • [36] Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP
    Qinjun Zhou
    Yongqiang Wei
    Fen Huang
    Xiaolei Wei
    Qi Wei
    Xiaoxiao Hao
    Yuankun Zhang
    Ru Feng
    International Journal of Hematology, 2016, 104 : 485 - 490
  • [37] Clinical behavior and treatment outcome of primary nasal diffuse large B-cell lymphoma
    Lu, Ning-Ning
    Li, Ye-Xiong
    Wang, Wei-Hu
    Jin, Jing
    Song, Yong-Wen
    Zhou, Li-Qiang
    Wang, Shu-Lian
    Liu, Yue-Ping
    Liu, Xin-Fan
    Yu, Zi-Hao
    CANCER, 2012, 118 (06) : 1593 - 1598
  • [38] Exploring the Impact of Diffuse Large B-Cell Lymphoma (International Prognostic Index [IPI] 2-5) on Clinical and Patient-Relevant Outcomes in the Context of a Clinical Trial
    Launonen, Aino
    Ho, Rodrigo
    Knapp, Andrea
    Ruiz, Irene Canales
    Simonella, Leonardo
    Thuresson, Per-Olof
    BLOOD, 2021, 138
  • [39] ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma
    Wu, Jingjing
    He, Zhengmei
    Zhu, Yaning
    Jiang, Chao
    Deng, Yuan
    Wei, Bin
    CURRENT CANCER DRUG TARGETS, 2021, 21 (01) : 80 - 89
  • [40] Fostamatinib for the treatment of diffuse large B-cell lymphoma.
    Arkenau, Hendrik-Tobias
    Patrikidou, Anna
    Flinn, Ian
    Hylton, Jonas C.
    Tong, Sandra
    Ardeshna, Kirit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345